WellCell Holdings Co., Limited announced that its substantial shareholder, WellCell Group Co., Limited, has signed three sale-and-purchase agreements after market close on 10 June 2026 to divest a combined 576.00 million shares, equivalent to 14.40% of the company’s issued share capital.

Key transaction terms • Volume and pricing: Each of the three individual buyers will acquire 192.00 million shares at HK$0.3445 per share, valuing each tranche at HK$66.14 million. The aggregate consideration for all agreements totals HK$198.43 million. • Completion window: Each disposal is scheduled to close within 20 business days of the respective agreement date, unless otherwise agreed by the parties. • Buyer profile: The three individual purchasers are, according to representations made to the company, independent of WellCell Holdings, its connected persons, and its concert parties, and will not trigger a mandatory general offer under the Takeovers Code.

Impact on shareholding structure • Pre-transaction: WellCell Group held 664.00 million shares, representing 16.60% of WellCell Holdings’ issued share capital. • Post-transaction (assuming no other changes): WellCell Group’s stake will fall to 88.00 million shares, or approximately 2.20%, resulting in its loss of “substantial shareholder” status under Hong Kong Listing Rules.

Board’s position The Board stated that the disposals are not expected to exert any adverse effect on the Group’s business operations or future prospects. Further announcements will be issued if required.

Investor caution Shareholders and potential investors are advised to exercise caution when dealing in the company’s securities.